LIVN Livanova

 
TIDMLIVN 
 
 
   02 November 2016 
 
   MISCELLANEOUS 
 
   LivaNova PLC (the "Company" or "LivaNova") today announced that it filed 
a Quarterly Report on Form 10-Q under the U.S. Securities Exchange Act 
of 1934, as amended, for  the nine months ended 30 September 2016 ("Form 
10-Q") with the U.S. Securities and Exchange Commission (the "SEC") on 
02 November 2016. 
 
   The Form 10-Q can be found on the SEC's website at www.sec.gov and in 
the Investor Relations section of the Company's website at 
www.livanova.com.  A copy of the Form 10-Q has been submitted to the 
National Storage Mechanism on the date of this announcement and is, or 
will be, available for inspection at 
http://www.morningstar.co.uk/uk/NSM. 
 
   About LivaNova 
 
   LivaNova PLC is a global medical technology company formed by the merger 
of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, 
and Cyberonics Inc., a medical device company with core expertise in 
neuromodulation.  LivaNova transforms medical innovation into meaningful 
solutions for the benefit of patients, healthcare professionals, and 
healthcare systems.  The Company employs approximately 4,600 employees 
worldwide and is headquartered in London, U.K.  With a presence in more 
than 100 countries, LivaNova operates as three business units: Cardiac 
Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating 
headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), 
respectively. 
 
   LivaNova is listed on NASDAQ and listed on the Official List of the UK's 
Financial Conduct Authority and traded on London Stock Exchange (LSE) 
under the ticker symbol "LIVN". 
 
   For more information, please visit www.livanova.com, or contact: 
 
   Investor Relations and Media 
 
   Karen King 
 
   Vice President, Investor Relations & Corporate Communications 
 
   Phone: +1 (281) 228-7262 
 
   Fax: +1 (281) 218-9332 
 
   e-mail: corporate.communications@livanova.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: LivaNova PLC via Globenewswire 
 
 
 
 

(END) Dow Jones Newswires

November 02, 2016 13:44 ET (17:44 GMT)

Grafico Azioni Livanova (LSE:LIVN)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Livanova (LSE:LIVN)
Storico
Da Giu 2023 a Giu 2024